Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Latest Updates of Viva's Portfolio Companies 2023-12-04 17:55
Supercell Acquires Exclusive Licensing from Japanese Immunotherapy Leader for Advanced NK Cell Treatment Technology 2023-12-04 16:39
First Patient Dosed in Phase Ⅲ Study of JSKN003 for the Treatment of Advanced HER2-Low Breast Cancer 2023-12-04 14:51
Nona Biosciences Announces Collaboration Agreement with Lycia Therapeutics 2023-12-04 13:19
First Patient Dosed in European Named Patient (Early Access) Program for TLX250-CDx, Telix's Kidney Cancer Imaging Agent 2023-12-04 13:00
VISTA Eye Specialist introduces CLEAR - a new generation eye surgery to help patients be glasses free again. 2023-12-04 09:38
The 3rd International Medical Innovation and Cooperation Forum convenes in Fangchenggang 2023-12-04 08:59
Everest Medicines Announces Investigational New Drug Application Acceptance of Zetomipzomib in China 2023-12-04 08:58
Media Tour Witnesses Chinese Modernization in Hainan FTP 2023-12-03 16:07
The highest incidence of OHCA is at home, with 3 cases of young OHCA occurring at home every week. 2023-12-01 21:29
280Bio doses first patient in Phase I clinical trial of TEB-17231, an oral pan-RAS inhibitor in patients with advanced cancers harboring mutations in KRAS, HRAS, or NRAS 2023-12-01 21:00
The Shanghai Cooperation Organization Traditional Medicine Forum opened 2023-12-01 17:49
GC Biopharma establishes mRNA production facility in Hwasun, Korea 2023-12-01 16:31
Sirnaomics Promotes Francois Lebel, M.D. to Chief Medical Officer 2023-12-01 14:41
Innovent Presents Clinical Data Update of IBI351 (KRAS G12C Inhibitor) Monotherapy in Lung Cancer and Colorectal Cancer at ESMO Asia Congress 2023 2023-12-01 12:00
CNN's 'Vital Signs' explores the prospects of phage therapy to treat drug-resistant superbugs 2023-12-01 11:29
Cerecin forges strategic partnership with A*STAR's Institute of Molecular and Cell Biology (IMCB) in Singapore to advance R&D in neurological disorders. 2023-12-01 09:34
Everest Medicines Announces Positive Topline Results from Induction Period of Etrasimod Phase 3 Clinical Trial Conducted in Asia for the Treatment of Moderate-to-Severe Active Ulcerative Colitis 2023-12-01 07:33
Biocon Biologics Successfully Completes Integration of Viatris' Biosimilar Business in 31 Countries in Europe 2023-12-01 03:53
Allotex Announces New Investor and Expansion of Production Facilities 2023-12-01 03:24
1 136 137 138 139 140 982